Related references
Note: Only part of the references are listed.Resilience to autosomal dominant Alzheimer's disease in a Reelin-COLBOS heterozygous man
Francisco Lopera et al.
NATURE MEDICINE (2023)
Differential sleep/wake response and sex differences following acute suvorexant, MK-1064 and zolpidem administration in the rTg4510 mouse model of tauopathy
Ryan J. Keenan et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Hypocretins (orexins): The ultimate translational neuropeptides
Laura H. Jacobson et al.
JOURNAL OF INTERNAL MEDICINE (2022)
Planning experiments: Updated guidance on experimental design and analysis and their reporting III
Michael J. Curtis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2022)
Decreased Orexin Receptor 1 mRNA Expression in the Locus Coeruleus in Both Tau Transgenic rTg4510 and Tau Knockout Mice and Accompanying Ascending Arousal System Tau Invasion in rTg4510
Ryan J. Keenan et al.
JOURNAL OF ALZHEIMERS DISEASE (2021)
Sleep/wake cycle alterations as a cause of neurodegenerative diseases: a mendelian randomization study
Natalia Cullell et al.
NEUROBIOLOGY OF AGING (2021)
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Introduction and Other Protein Targets
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2021)
The contribution of orexins to sex differences in the stress response
Laura A. Grafe et al.
BRAIN RESEARCH (2020)
Bidirectional relationship between sleep and Alzheimer's disease: role of amyloid, tau, and other factors
Chanung Wang et al.
NEUROPSYCHOPHARMACOLOGY (2020)
Hypnotics with novel modes of action
Daniel Hoyer et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2020)
Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial
W. Joseph Herring et al.
ALZHEIMERS & DEMENTIA (2020)
Suvorexant ameliorates cognitive impairments and pathology in APP/PS1 transgenic mice
Fang Zhou et al.
NEUROBIOLOGY OF AGING (2020)
Effects of orexin receptor antagonism on human sleep architecture: A systematic review
Jacob W. Clark et al.
SLEEP MEDICINE REVIEWS (2020)
ARRIVE 2.0 and the British Journal of Pharmacology: Updated guidance for 2020
Elliott Lilley et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research
Nathalie Percie du Sert et al.
BRITISH JOURNAL OF PHARMACOLOGY (2020)
Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration
C. M. Holton et al.
ALZHEIMERS RESEARCH & THERAPY (2020)
The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans
Jerrah K. Holth et al.
SCIENCE (2019)
Validation of 'Somnivore', a Machine Learning Algorithm for Automated Scoring and Analysis of Polysomnography Data
Giancarlo Allocca et al.
FRONTIERS IN NEUROSCIENCE (2019)
MRtrix3: A fast, flexible and open software framework for medical image processing and visualisation
J-Donald Tournier et al.
NEUROIMAGE (2019)
Goals and practicalities of immunoblotting and immunohistochemistry: A guide for submission to the British Journal of Pharmacology
Steve P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2018)
Early intervention of tau pathology prevents behavioral changes in the rTg4510 mouse model of tauopathy
Xiaohai Wang et al.
PLOS ONE (2018)
Chronic Sleep Disruption Advances the Temporal Progression of Tauopathy in P301S Mutant Mice
Yan Zhu et al.
JOURNAL OF NEUROSCIENCE (2018)
Z-drugs and risk for falls and fractures in older adults-a systematic review and meta-analysis
Nir Treves et al.
AGE AND AGEING (2018)
The release and trans-synaptic transmission of Tau via exosomes
Yipeng Wang et al.
MOLECULAR NEURODEGENERATION (2017)
Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis
Karen Donnelly et al.
PLOS ONE (2017)
Identification of the Tau phosphorylation pattern that drives its aggregation
Clement Despres et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Tracking progressive pathological and functional decline in the rTg4510 mouse model of tauopathy
Thomas Blackmore et al.
ALZHEIMERS RESEARCH & THERAPY (2017)
Altered sleep and EEG power in the P301S Tau transgenic mouse model
Jerrah K. Holth et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2017)
Precortical Phase of Alzheimer's Disease (AD)-Related Tau Cytoskeletal Pathology
Katharina Stratmann et al.
BRAIN PATHOLOGY (2016)
Neuronal activity enhances tau propagation and tau pathology in vivo
Jessica W. Wu et al.
NATURE NEUROSCIENCE (2016)
Mutant Tau knock-in mice display frontotemporal dementia relevant behaviour and histopathology
David J. Koss et al.
NEUROBIOLOGY OF DISEASE (2016)
Causal evidence for the role of REM sleep theta rhythm in contextual memory consolidation
Richard Boyce et al.
SCIENCE (2016)
Orexin 2 Receptor Antagonism is Sufficient to Promote NREM and REM Sleep from Mouse to Man
Anthony L. Gotter et al.
SCIENTIFIC REPORTS (2016)
Hyperactivity with Agitative-Like Behavior in a Mouse Tauopathy Model
Pia Jul et al.
JOURNAL OF ALZHEIMERS DISEASE (2016)
Locus Coeruleus and Tuberomammillary Nuclei Ablations Attenuate Hypocretin/Orexin Antagonist-Mediated REM Sleep
Michael D. Schwartz et al.
ENEURO (2016)
The preclinical phase of the pathological process underlying sporadic Alzheimer's disease
Heiko Braak et al.
BRAIN (2015)
Sleep Interacts with Aβ to Modulate Intrinsic Neuronal Excitability
Masashi Tabuchi et al.
CURRENT BIOLOGY (2015)
Analysis of tau post-translational modifications in rTg4510 mice, a model of tau pathology
Lixin Song et al.
MOLECULAR NEURODEGENERATION (2015)
Transcranial Slow Oscillation Stimulation During Sleep Enhances Memory Consolidation in Rats
Sonja Binder et al.
BRAIN STIMULATION (2014)
Discovery of 5-Chloro-N-[( 5,6-dimethoxypyridin-2-yl)methyl]-2,2′:5′,3-terpyridine-3′-carboxamide (MK-1064): A Selective Orexin 2 Receptor Antagonist (2-SORA) for the Treatment of Insomnia
Anthony J. Roecker et al.
CHEMMEDCHEM (2014)
The Effect of Two Benzodiazepine Receptor Agonist Hypnotics on Sleep-Dependent Memory Consolidation
Janine M. Hall-Porter et al.
JOURNAL OF CLINICAL SLEEP MEDICINE (2014)
Potential role of orexin and sleep modulation in the pathogenesis of Alzheimer's disease
Jee Hoon Roh et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Neuronal activity regulates extracellular tau in vivo
Kaoru Yamada et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Impairment of Glymphatic Pathway Function Promotes Tau Pathology after Traumatic Brain Injury
Jeffrey J. Iliff et al.
JOURNAL OF NEUROSCIENCE (2014)
Sleep and Alzheimer disease pathology-a bidirectional relationship
Yo-El S. Ju et al.
NATURE REVIEWS NEUROLOGY (2014)
Orexin-1 receptor blockade dysregulates REM sleep in the presence of orexin-2 receptor antagonism
Christine Dugovic et al.
FRONTIERS IN NEUROSCIENCE (2014)
The hypocretin/orexin antagonist almorexant promotes sleep without impairment of performance in rats
Stephen R. Morairty et al.
FRONTIERS IN NEUROSCIENCE (2014)
The sleep-wake cycle and Alzheimer's disease: what do we know?
Miranda M. Lim et al.
NEURODEGENERATIVE DISEASE MANAGEMENT (2014)
The duration of sleep promoting efficacy by dual orexin receptor antagonists is dependent upon receptor occupancy threshold
Anthony L. Gotter et al.
BMC NEUROSCIENCE (2013)
Physiological release of endogenous tau is stimulated by neuronal activity
Amy M. Pooler et al.
EMBO REPORTS (2013)
Brain-wide pathway for waste clearance captured by contrast-enhanced MRI
Jeffrey J. Iliff et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Identification of a Novel Series of Orexin Receptor Antagonists with a Distinct Effect on Sleep Architecture for the Treatment of Insomnia
Claudia Betschart et al.
JOURNAL OF MEDICINAL CHEMISTRY (2013)
Synthetic Tau Fibrils Mediate Transmission of Neurofibrillary Tangles in a Transgenic Mouse Model of Alzheimer's-Like Tauopathy
Michiyo Iba et al.
JOURNAL OF NEUROSCIENCE (2013)
Sleep Drives Metabolite Clearance from the Adult Brain
Lulu Xie et al.
SCIENCE (2013)
Distinct effects of IPSU and suvorexant on mouse sleep architecture
Daniel Hoyer et al.
FRONTIERS IN NEUROSCIENCE (2013)
Fiji: an open-source platform for biological-image analysis
Johannes Schindelin et al.
NATURE METHODS (2012)
Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment
Arnold Bakker et al.
NEURON (2012)
Sleep Oscillations in the Thalamocortical System Induce Long-Term Neuronal Plasticity
Sylvain Chauvette et al.
NEURON (2012)
Dual Hypocretin Receptor Antagonism Is More Effective for Sleep Promotion than Antagonism of Either Receptor Alone
Stephen R. Morairty et al.
PLOS ONE (2012)
Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model
Pascal E. Sanchez et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A Paravascular Pathway Facilitates CSF Flow Through the Brain Parenchyma and the Clearance of Interstitial Solutes, Including Amyloid β
Jeffrey J. Iliff et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Disruption of the Sleep-Wake Cycle and Diurnal Fluctuation of Amyloid-β in Mice with Alzheimer's Disease Pathology
Jee Hoon Roh et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
The Dual Orexin Receptor Antagonist Almorexant Induces Sleep and Decreases Orexin-Induced Locomotion by Blocking Orexin 2 Receptors
Geraldine M. Mang et al.
SLEEP (2012)
The pathological process underlying Alzheimer's disease in individuals under thirty
Heiko Braak et al.
ACTA NEUROPATHOLOGICA (2011)
Differential Roles of Orexin Receptor-1 and-2 in the Regulation of Non-REM and REM Sleep
Michihiro Mieda et al.
JOURNAL OF NEUROSCIENCE (2011)
Neuronal activity regulates the regional vulnerability to amyloid-β deposition
Adam W. Bero et al.
NATURE NEUROSCIENCE (2011)
Sex difference in pathology and memory decline in rTg4510 mouse model of tauopathy
Mei Yue et al.
NEUROBIOLOGY OF AGING (2011)
Discovery of the Dual Orexin Receptor Antagonist [(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone (MK-4305) for the Treatment of Insomnia
Christopher D. Cox et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
SLEEP The memory function of sleep
Susanne Diekelmann et al.
NATURE REVIEWS NEUROSCIENCE (2010)
Amyloid-β Dynamics Are Regulated by Orexin and the Sleep-Wake Cycle
Jae-Eun Kang et al.
SCIENCE (2009)
Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers
S. Otmani et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2008)
Endocytosis is required for synaptic activity-dependent release of amyloid-β in vivo
John R. Cirrito et al.
NEURON (2008)
Boosting slow oscillations during sleep potentiates memory
Lisa Marshall et al.
NATURE (2006)
User-guided 3D active contour segmentation of anatomical structures: Significantly improved efficiency and reliability
Paul A. Yushkevich et al.
NEUROIMAGE (2006)
Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
JR Cirrito et al.
NEURON (2005)
Age-dependent neurofibrillary tangle formation, neuron loss, and memory impairment in a mouse model of human tauopathy (P301L)
M Ramsden et al.
JOURNAL OF NEUROSCIENCE (2005)
Daytime sleepiness in mild and moderate Alzheimer's disease and its relationship with cognitive impairment
E Bonanni et al.
JOURNAL OF SLEEP RESEARCH (2005)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Sleep disturbance in mild to moderate Alzheimer's disease
M Moran et al.
SLEEP MEDICINE (2005)
Residual effects of middle-of-the-night administration of zaleplon and zolpidem on driving ability, memory functions, and psychomotor performance
JC Verster et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2002)
Share Paper
